Commentary

This paper was presented at the conference "Policies to Promote Affordable Housing," cosponsored by the Federal Reserve Bank of New York and New York University's Furman Center for Real Estate and Urban Policy, February 7, 2002. It was part of Session 3: The Impact of Housing on People and Places, and is a commentary on "The impacts of new neighborhoods on poor families: evaluating the policy implications of the moving to opportunity demonstration" by John Goering.Housing ; Housing policy ; Poverty ; Demography

A Multi-Criteria Analysis Approach to Repository Evaluation

In 2020, the University of South Carolina Libraries began evaluating repository platforms to determine whether the software in use for our institutional and digital repositories could be replaced at an equal or lower cost. Using a multi-criteria analysis (MCA) approach, a primary group of stakeholders, with input from individuals invested in the repositories, embarked on an ongoing evaluation of existing software and alternative solutions. This approach has allowed us to evaluate a substantial number of conflicting criteria to effectively assess the possibility of one or more repository migrations. In this presentation, we will discuss our use of the MCA approach, the evaluation process, and the insights we gleaned. Additionally, we will offer suggestions learned from our experience for libraries considering a similar evaluation

Residential Segregation in North Carolina

When blacks and whites reacted so differently to the verdict of the O.J. Simpson trial, many observers commented that it was almost as though the two races inhabited two different worlds. Unfortunately, this comment is not as much an exaggeration as many would think. Although blacks are increasingly present in corporate America, the entertainment industry, politics, and other spheres of public life, blacks and whites for the most part still live in separate residential communities. Research by social scientists has found that levels of residential segregation (hereafter referred to as segregation) between blacks and whites remained high in most metropolitan regions as of 1990 (Farley and Frey 1994). This is true even though more than a quarter of a century has elapsed since the passage of the 1968 Fair Housing Act. This article discusses the causes and consequences of segregation. Data is presented to illustrate segregation levels in North Carolina by county, based on the 1990 census. To conclude, the article discusses the policy implications of segregation

Fish Assemblages on a Mitigation Boulder Reef and Neighboring Hardbottom

We compared the fish assemblages on a mitigation site to neighboring natural habitat. Artificial reefs made of limestone boulders were deployed offshore Florida in August–September 2003 as mitigation for an anticipated nearshore hardbottom burial associated with a planned beach nourishment. Boulders comprising a footprint of 36,017 m2 were deployed on sand substrate, adjacent to hardbottom, to replace an expected covering of 30,756 m2 hardbottom. Nourishment of the beach was initiated May 2005 and completed in February 2006. Fishes on the artificial mitigation reefs and neighboring natural hardbottom were counted annually in August, 2004 through 2008, with 30-m belt transects and rover-diver surveys. Across all surveys a total of 18,313 fish of 185 species was counted. Mean species richness and abundance were typically greater on the transects at mitigation reefs than on nearshore hardbottom (NHB). MDS plots of Bray–Curtis similarity indices show a clear distinction between the mitigation reefs and NHB fish assemblages regardless if the data were, or were not, standardized to account for rugosity differences. SIMPER analysis indicated the two assemblages had, on average, 75% dissimilarity. Thus, while the mitigation boulders exhibited greater abundance and species richness than the NHB, the two assemblages differed dramatically in structure. The mitigation reefs provided a habitat suitable for fish colonization. However, this habitat differed dramatically in size and appearance from impacted NHB and created a unique environment unlike the NHB. Thus, mitigation reefs in general, and boulder reefs specifically, should not be relied upon to provide an equitable replacement to NHB habitat loss

Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer

Introduction/Background. Nonmetastatic castrate resistant prostate cancer (CRPC) is a challenging disease state. The objective of this study was to evaluate the efficacy and tolerability of bevacizumab in nonmetastatic CRPC patients. Patients. Patients with prostate cancer who developed PSA recurrence after local therapy were included if they had absence of bone or visceral metastases and PSA progression despite androgen deprivation therapy. Methods. Bevacizumab 10 mg/kg intravenously was administered every 14 days until PSA progression, development of metastasis, or unacceptable toxicity. Results. 15 patients were enrolled and treated with bevacizumab for a median duration of 3.1 months. Median baseline PSA was 27 ng/mL, and seven patients had Gleason Score ≥8. Five patients had declined in PSA during the treatment. Median PSA doubling time was prolonged from 4.7 months pretreatment to 6.5 months. Median time to PSA progression and new metastasis were 2.8 and 7.9 months, respectively. There were three grade 3 adverse events (one proteinuria and two hypertension) and one pulmonary embolism. There was no treatment-related mortality. Conclusion. Bevacizumab therapy had minimal impact on the disease course of nonmetastatic CRPC, and investigation of novel strategies is needed

Long‐term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin‐converting enzymes/angiotensin receptor blockers: results from AMETHYST‐DN

AimsChronic kidney disease (CKD) in heart failure (HF) increases the risk of hyperkalaemia (HK), limiting angiotensin‐converting enzyme inhibitor (ACE‐I) or angiotensin receptor blocker (ARB) use. Patiromer is a sodium‐free, non‐absorbed potassium binder approved for HK treatment. We retrospectively evaluated patiromer’s long‐term safety and efficacy in HF patients from AMETHYST‐DN.Methods and resultsPatients with Type 2 diabetes, CKD, and HK [baseline serum potassium >5.0–5.5 mmol/L (mild) or >5.5–88%) and moderate (≥73%) HK had normokalaemia at each visit from Weeks 12 to 52. Three HF patients were withdrawn because of high (n = 1) or low (n = 2) serum potassium. The most common patiromer‐related adverse event was hypomagnesaemia (8.6%).ConclusionsIn patients with a clinical diagnosis of HF, diabetes, CKD, and HK on ACE‐I/ARB, patiromer was well tolerated and effective for HK treatment over 52 weeks.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/145406/1/ehf212292.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/145406/2/ehf212292_am.pd

Linear modeling of possible mechanisms for parkinson tremor generation

The power of Parkinson tremor is expressed in terms of possibly changed frequency response functions between relevant variables in the neuromuscular system. The derivation starts out from a linear loopless equivalent model of mechanisms for general tremor generation. Hypothetical changes in this model from the substrate of the disease are indicated, and possible ones are inferred from literature about experiments on patients. The result indicates that in these patients tremor appears to have been generated in loops, which did not include the brain area which in surgery usually is inactivated. For some patients in the literature, these loops could involve muscle length receptors, the static sensitivity of which may have been enlarged by pathological brain activity

MRI-targeted or standard biopsy for prostate-cancer diagnosis

Background Multiparametric magnetic resonance imaging (MRI), with or without targeted biopsy, is an alternative to standard transrectal ultrasonography-guided biopsy for prostate-cancer detection in men with a raised prostate-specific antigen level who have not undergone biopsy. However, comparative evidence is limited. Methods In a multicenter, randomized, noninferiority trial, we assigned men with a clinical suspicion of prostate cancer who had not undergone biopsy previously to undergo MRI, with or without targeted biopsy, or standard transrectal ultrasonography-guided biopsy. Men in the MRI-targeted biopsy group underwent a targeted biopsy (without standard biopsy cores) if the MRI was suggestive of prostate cancer; men whose MRI results were not suggestive of prostate cancer were not offered biopsy. Standard biopsy was a 10-to-12-core, transrectal ultrasonography-guided biopsy. The primary outcome was the proportion of men who received a diagnosis of clinically significant cancer. Secondary outcomes included the proportion of men who received a diagnosis of clinically insignificant cancer. Results A total of 500 men underwent randomization. In the MRI-targeted biopsy group, 71 of 252 men (28%) had MRI results that were not suggestive of prostate cancer, so they did not undergo biopsy. Clinically significant cancer was detected in 95 men (38%) in the MRI-targeted biopsy group, as compared with 64 of 248 (26%) in the standard-biopsy group (adjusted difference, 12 percentage points; 95% confidence interval [CI], 4 to 20; P=0.005). MRI, with or without targeted biopsy, was noninferior to standard biopsy, and the 95% confidence interval indicated the superiority of this strategy over standard biopsy. Fewer men in the MRI-targeted biopsy group than in the standard-biopsy group received a diagnosis of clinically insignificant cancer (adjusted difference, -13 percentage points; 95% CI, -19 to -7; P<0.001). Conclusions The use of risk assessment with MRI before biopsy and MRI-targeted biopsy was superior to standard transrectal ultrasonography-guided biopsy in men at clinical risk for prostate cancer who had not undergone biopsy previously. (Funded by the National Institute for Health Research and the European Association of Urology Research Foundation; PRECISION ClinicalTrials.gov number, NCT02380027 .)

Asteroids Inside Out: Radar Tomography

n/